Peregrine Pharma (PPHM) Files $150M Mixed Shelf

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Warrants, or a combination of the two.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• Jupiter Neurosciences prices $2M registered direct offering of shares
• loanDepot receives NYSE non-compliance notice over stock price